Great news: The anti-cronervirus medicine results in success, distributed free in Italy

Illici Tocizumab, who is considered a treatment therapy for coronary patients, has begun to distribute for citizens in Italy who are laid out in intensive and critical therapy departments, writes Metro newspaper. As noted by the media so far, the medicine has produced encouraging results [...]
As noted by the media so far, the drug has produced encouraging results in 50 percent of patients who have just begun to undergo treatment.
The company that produces this drug has announced it will distribute it free in each region of Italy, which will submit the application.
This company is being organised to have all the necessary reserves and through the bloody administrator Maurizio De Cioco seek out from the Italian National Drug Agency, a protocol as soon as possible to avoid abuses in the improper use of Tocilluzumb and on the other hand to provide positive answers to patients with Covid 19.
The Marche region reports that 8 out of 11 patients who have used Tocizumab have responded very well to the treatment.
For the first time, the drug Tocilluzumm, which is not an antiviral medicine but is used in anti-artery and rheumatism therapies, was applied by Dr. Paolo Ascierto to 2 positive coronary patients laid down at the Naples hospital.
The same ones have had notable improvement within 24 hours, leading the state to seek their use in all Italian hospitals.
We remember that until now, nearly 2,000 deaths in Italy are reported, becoming the second most affected by the Ovid 19 virus after China, where it first emerged.











